SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COMMON STOCK
Total 13F shares
9,853,493
Share change
-2,462,415
Total reported value
$16,752,000
Put/Call ratio
67%
Price per share
$1.70
Number of holders
35
Value change
-$4,957,108
Number of buys
14
Number of sells
26

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q3 2017

As of 30 Sep 2017 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 9,853,493 shares of stock of the company.
Largest 10 holders included Wildcat Capital Management, LLC, VANGUARD GROUP INC, Intellectus Partners, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/.
This table shows 35 institutional shareholders of the security as of 30 Sep 2017.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.